Literature DB >> 2875415

Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine.

P B Bradley, G Engel, W Feniuk, J R Fozard, P P Humphrey, D N Middlemiss, E J Mylecharane, B P Richardson, P R Saxena.   

Abstract

As a result of controversy in the literature regarding the classification and nomenclature of functional receptors for 5-hydroxytryptamine (5-HT), a framework for classification is proposed. The formulation of these proposals has only been made possible by the recent advent of new drug tools. It is considered that there are three main types of 5-HT receptor, two of which have been well characterised pharmacologically, using selective antagonists, and which it is proposed to name 5-HT2 and 5-HT3. These two groups broadly encompass the "D" and "M" receptors, respectively, which Gaddum identified in the guinea-pig ileum (Gaddum and Picarelli, 1957). The 5-HT2 receptor, which mediates a variety of actions of 5-HT, has been definitively shown to correlate with the 5-HT2 binding site in the brain. No binding studies in brain tissue have yet been published with radiolabelled ligands specific for 5-HT3 receptors. A number of other actions of 5-HT appear to be mediated via receptors distinct from 5-HT2 or 5-HT3 receptors. Since selective antagonists are not yet available, these receptors cannot be definitively characterised, although in many cases they do have some similarities with 5-HT1 binding sites, which are a heterogeneous entity. Criteria are proposed for tentatively classifying these receptors as "5-HT1-like" (Table 1). Definitive characterisation of these receptors will await the identification of specific antagonists. This classification of 5-HT receptors into three main groups (Table 1) is based largely, but not exclusively, on data from studies in isolated peripheral tissues where definitive classification is possible. However, it is believed that this working classification will be relevant to functional responses to 5-HT in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2875415     DOI: 10.1016/0028-3908(86)90207-8

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  278 in total

1.  Pharmacological characterization of the 5-HT receptor-mediated contraction in the mouse isolated ileum.

Authors:  B R Tuladhar; M D Womack; R J Naylor
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Characterization of the 5-hydroxytryptamine receptors mediating contraction in the intestine of Suncus murinus.

Authors:  F A Javid; R J Naylor
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

3.  Molecular cloning, pharmacological properties and tissue distribution of the porcine 5-HT(1B) receptor.

Authors:  P Bhalla; H S Sharma; X Ma; T Wurch; P J Pauwels; P R Saxena
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

4.  5-HT1D binding sites in porcine brain can be sub-divided by GR43175.

Authors:  M J Sumner; P P Humphrey
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

Review 5.  Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders.

Authors:  Marcello Leopoldo; Enza Lacivita; Francesco Berardi; Roberto Perrone; Peter B Hedlund
Journal:  Pharmacol Ther       Date:  2010-10-20       Impact factor: 12.310

6.  The effects of ageing on prejunctional 5-hydroxytryptamine receptors in the rat vas deferens.

Authors:  M Borton; J R Docherty
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

7.  Different regulation of serotonin receptors following adrenal hormone imbalance in the rat hippocampus and hypothalamus.

Authors:  M Martire; G Pistritto; P Preziosi
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

8.  The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons.

Authors:  A Dumuis; M Sebben; J Bockaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

9.  Stimulation of breathing movements by L-5-hydroxytryptophan in fetal sheep during normoxia and hypoxia.

Authors:  D J Fletcher; M A Hanson; P J Moore; J G Nijhuis; M J Parkes
Journal:  J Physiol       Date:  1988-10       Impact factor: 5.182

10.  Bacterially expressed human serotonin receptor 3A is functionally reconstituted in proteoliposomes.

Authors:  Jung-Hyun Na; Jaeil Shin; Yuna Jung; Dongbin Lim; Yeon-Kyun Shin; Yeon Gyu Yu
Journal:  Protein Expr Purif       Date:  2013-01-12       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.